⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MIRA News
MIRA Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
MIRA
MIRA Pharmaceuticals Secures Worldwide Exclusive Rights to MIRA-55 and SKNY-1
accessnewswire.com
MIRA
Form 8-K
sec.gov
MIRA
MIRA Pharmaceuticals Secures Worldwide Rights for Ketamir-2, Expanding Global IP Portfolio Across 10 Major Markets Ahead of Phase 2a in CIPN
accessnewswire.com
MIRA
MIRA Pharmaceuticals Reports Positive Unblinded Phase 1 Data for Ketamir-2
accessnewswire.com
MIRA
Form 8-K
sec.gov
MIRA
MIRA Pharmaceuticals Announces Acceptance of Peer-Reviewed SKNY-1 Manuscript Highlighting Oral Obesity and Nicotine Addiction Drug Candidate
accessnewswire.com
MIRA
Form 8-K
sec.gov
MIRA
Miracell Receives FDA 510(k) Clearance for SMART M-CELL PRP Concentration System and SMART M-CELL Bone Marrow Concentration System
prnewswire.com
MIRA
Form 8-K
sec.gov
MIRA